Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19
Akiyoshi Takami
Topics & Concepts
Hemophagocytic lymphohistiocytosisEtoposideCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)HematologyPandemicInternal medicineVirologyPediatricsChemotherapyInfectious disease (medical specialty)OutbreakDiseaseAutoimmune and Inflammatory Disorders ResearchImmune Cell Function and InteractionChildhood Cancer Survivors' Quality of Life